Eric Tardif is a well-known corporate leader and life sciences professional. Based in the San Francisco metro area, Mr. Tardif is a co-founder and partner of Maravai LifeSciences, a firm dedicated to the research and development of disease therapeutics. For nearly 20 years, Eric’s career experiences and education have led him to acquire a keen understanding of finances and corporate development strategies. His leadership and dedication to creating medical solutions have helped him to stand out in a competitive marketplace.
Eric Tardif is a graduate of Bishop’s University in Sherbrooke, Quebec, earning a Bachelor of Arts in Business in 1990. At Bishop’s University, he was active in student societies and served as the President of Beta Theta Pi.
In 1993, he was accepted into the Master of Business Administration program at the University of British Columbia in Vancouver. Rigorous coursework prepared him for the challenges he would face as a financial professional and as a corporate principal. He earned his MBA from the University in 1994.
His professional education continued in 1996 when he was accepted to the prestigious Boston College Carroll School of Management. In 1998, he earned a Master of Science in Finance from the school. His educational experiences allowed him to develop a command of complex business and private equity strategies; later, he would leverage these skills to launch Maravai LifeSciences.
After working in the finance field for several years after his Boston College education, Eric Tardif was appointed to the role of Managing Director in Morgan Stanley’s Healthcare Investment Banking division. Here, he was exposed to the complexity of healthcare financing for the first time. Over a three-year period with Morgan Stanley, he helped to spearhead innovative investment programs for healthcare operations, giving them the security to succeed in their endeavors.
In 2009, Eric joined the team at Gen Probe, a medical diagnostics developer and manufacturer in the San Diego area. He served as the Senior Vice President of Corporate Development. In this role, he was responsible for corporate strategy, mergers & acquisitions, and business development. Through his leadership, Gen Probe was prepared for an eventual acquisition by Hologic. Eric stayed after the acquisition and served in two capacities for Hologic, first as Senior Vice President in Commercial Operations and then as the Senior Vice President of Corporate Strategy. In a dynamic healthcare sector, Eric’s experience and understanding of finances helped position the company for lucrative developments in medical diagnostic solutions.
In 2014, Eric Tardif decided to forge his own path in the life sciences industry. Partnering with Carl Hull and GTCR, a private equity firm, Eric launched Maravai Life Sciences. His goal was to build a transformative life sciences products company by acquiring businesses aligned with his vision. Through business incubation and strategic investments, Maravai has grown tremendously in the industry. Acquisitions of laboratory and diagnostic firms like Vector Laboratories have created a foundation for long-term success in the healthcare industry. Eric Tardif remains active with the company, working to identify emerging opportunities and markets and to use his expertise in corporate strategy to produce significant business growth.